Shaoxing Xingxin New Material Co.,Ltd (SHE:001358)
China flag China · Delayed Price · Currency is CNY
28.41
-0.67 (-2.30%)
Jan 26, 2026, 1:15 PM CST

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Piperazine Series
405.91M
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series Growth
-26.00%
Log In
Log In
Log In
Log In
Upgrade
Amide Series
32.43M
Log In
Log In
Log In
Log In
Upgrade
Amide Series Growth
28.65%
Log In
Log In
Log In
Log In
Upgrade
Other
29.80M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-47.25%
Log In
Log In
Log In
Log In
Upgrade
Other Business
-
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - N-Hydroxyethylpiperazine
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - N-Hydroxyethylpiperazine Growth
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Triethylene Diamine
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Triethylene Diamine Growth
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Desulfurization and Decarbonization Agent
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Desulfurization and Decarbonization Agent Growth
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - N-Methylpiperazine
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - N-Methylpiperazine Growth
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - N-Ethylpiperazine
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - N-Ethylpiperazine Growth
-
Log In
Log In
Log In
Log In
Upgrade
Amide Series - N,N-Dimethylpropane Amide
-
Log In
Log In
Log In
Log In
Upgrade
Amide Series - N,N-Dimethylpropane Amide Growth
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Anhydrous Piperazine
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Anhydrous Piperazine Growth
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Other Piperazine Series Product
-
Log In
Log In
Log In
Log In
Upgrade
Piperazine Series - Other Piperazine Series Product Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
29.80M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-47.25%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
China
468.14M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-25.72%
Log In
Log In
Log In
Log In
Upgrade
Asia
-
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade